Peptide Record

Thymosin beta-4 · full corpus

Explore

Every evidence record, mention, review and regulatory filing collected for Thymosin beta-4, in one list. Each row links to the original. Nothing here is summarised for you — this is the corpus, source tag by source tag.

1,396 records · ordered by source hierarchy — human trials first, vendor material last

Corpus records for Thymosin beta-4
SourceKindRecordAttributionDetailDate
PRECLINICALevidenceThymosin beta4: structure, function, and biological properties supporting current and future clinical applications.Tbeta4Wound healing2010-04-01
PRECLINICALevidenceThymosin beta4 and corneal wound healing: visions of the future.Tbeta4—2010-04-01
PRECLINICALevidenceTreatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4.Tbeta4Wound healing2010-04-01
PRECLINICALevidenceAnimal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide.Tbeta4Inflammation2010-04-01
PRECLINICALevidencePhotorhabdus luminescens toxins ADP-ribosylate actin and RhoA to force actin clustering.Thymosin beta 4—2010-02-26
PRECLINICALevidenceThymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells.Tbeta4Skin appearance & aging · preclinical2010-02-16
PRECLINICALevidenceDifferent thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract.Tbeta4Gut barrier & GI healing · preclinical2010-02-09
PRECLINICALevidenceSerum thymosin beta4 levels in patients with hepatitis B virus-related liver failure.Thymosin beta 4Liver health2010-02-07
PRECLINICALevidenceThymosin beta-4 directs cell fate determination of human mesenchymal stem cells through biophysical effects.Tbeta4—2010-01-01
PRECLINICALevidenceThymosin beta4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.Tbeta4—2010-01-01
PRECLINICALevidenceThymosin-beta4 attenuates ethanol-induced neurotoxicity in cultured cerebral cortical astrocytes by inhibiting apoptosis.Tbeta4—2010-01-01
PRECLINICALevidenceNeurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.Tbeta4—2009-12-29
PRECLINICALevidenceThymosin beta4 induces epicardium-derived neovascularization in the adult heart.Tbeta4—2009-12-01
PRECLINICALevidenceExogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro.Thymosin beta 4—2009-12-01
PRECLINICALevidenceExogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro.TB4—2009-12-01
PRECLINICALevidenceElevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells.Tbeta4Inflammation2009-11-15
PRECLINICALevidenceActin filament nucleation and elongation factors--structure-function relationships.Tbeta4—2009-11-01
PRECLINICALevidenceNano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.Thymosin beta 4Inflammation2009-11-01
PRECLINICALevidenceThe beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family.Thymosin beta 4—2009-10-01
PRECLINICALevidenceCell-responsive hydrogel for encapsulation of vascular cells.Tbeta4—2009-09-01
PRECLINICALevidenceIdentification of integrins alpha6 and beta7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells.Thymosin β4Skin appearance & aging · preclinical2009-09-01
PRECLINICALevidenceObservation of NMR signals from proteins introduced into living mammalian cells by reversible membrane permeabilization using a pore-forming toxin, streptolysin O.Tbeta4preclinical2009-08-12
PRECLINICALevidenceOverexpression of thymosin beta4 increases pseudopodia formation in LNCaP prostate cancer cells.Thymosin beta 4preclinical2009-06-01
PRECLINICALevidenceThymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.Thymosin beta 4—2009-05-01
PRECLINICALevidenceThymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.TB4—2009-05-01
PRECLINICALevidenceStudy of the human plasma proteome of rheumatoid arthritis.Thymosin β4—2009-04-17
PRECLINICALevidenceThe mouse thymosin beta15 gene family displays unique complexity and encodes a functional thymosin repeat.TB4—2009-04-10
PRECLINICALevidenceThymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1.Thymosin beta 4Immune function · preclinical2009-03-24
PRECLINICALevidenceThymosin beta4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway.Thymosin beta 4preclinical2009-03-01
PRECLINICALevidence[Actin in the wound healing process].Thymosin beta 4—2009-01-01
PRECLINICALevidenceOverexpression of thymosin beta-10 inhibits VEGF mRNA expression, autocrine VEGF protein production, and tube formation in hypoxia-induced monkey choroid-retinal endothelial cells.TB4Eye & vision health2009-01-01
PRECLINICALevidenceThymosin beta(4) and beta(10) levels in pre-term newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development.Thymosin beta 4—2009-01-01
PRECLINICALevidenceOverexpression of thymosin beta-10 inhibits VEGF mRNA expression, autocrine VEGF protein production, and tube formation in hypoxia-induced monkey choroid-retinal endothelial cells.Thymosin beta 4—2009-01-01
PRECLINICALevidenceCollateral circulation: past and present.Thymosin beta 4—2009-01-01
PRECLINICALevidenceNeuropeptides and thymic hormones in the Xenopus thymus.Thymosin β4—2009-01-01
PRECLINICALevidenceHPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10).Tbeta4—2009-01-01
PRECLINICALevidencePAI-1 and kidney fibrosis.Thymosin b4—2009-01-01
PRECLINICALevidenceQuantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.TB4—2008-12-01
PRECLINICALevidenceQuantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.Thymosin β4—2008-12-01
PRECLINICALevidenceIncreased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients.Thymosin beta 4—2008-11-01
PRECLINICALevidenceMALDI-MS derived prognostic protein markers for resected non-small cell lung cancer.Thymosin β4—2008-10-01
PRECLINICALevidenceThymosin beta4 is cytoprotective in human gingival fibroblasts.Tbeta4preclinical2008-10-01
PRECLINICALevidenceOverexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors.Thymosin β4—2008-09-01
PRECLINICALevidenceAcute electrical stimulation of nucleus ambiguus enhances immune function in rats.Thymosin beta 4Immune function2008-09-01
PRECLINICALevidenceEmbryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin beta4.Thymosin beta 4—2008-08-01
PRECLINICALevidenceThymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage.Thymosin beta 4Longevity & cellular aging · preclinical2008-07-01
PRECLINICALevidenceThymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment.Thymosin beta 4preclinical2008-06-25
PRECLINICALevidenceHypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells.TB4—2008-06-08
PRECLINICALevidenceHypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells.Thymosin beta 4—2008-06-08
PRECLINICALevidenceThymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.Tbeta4—2008-04-29